These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 9072591

  • 1. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK, Rao GS, Smith DS, Andriole GL.
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [Abstract] [Full Text] [Related]

  • 2. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT, Flynn TJ, Kynaston HG, Golash A, Hart A, Kim HL, Gerber GS.
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [Abstract] [Full Text] [Related]

  • 3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J, Högstedt B.
    Scand J Urol Nephrol; 2002 Sep; 36(5):330-8. PubMed ID: 12487736
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M, Sheir KZ, El-Baz M, Ibrahiem el-H.
    Scand J Urol Nephrol; 2005 Sep; 39(1):49-55. PubMed ID: 15764271
    [Abstract] [Full Text] [Related]

  • 6. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 7. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM.
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [Abstract] [Full Text] [Related]

  • 8. Complications following combined transrectal ultrasound-guided prostate needle biopsies and transurethral resection of the prostate.
    Shen BY, Chang PL, Lee SH, Chen CL, Tsui KH.
    Arch Androl; 2006 Sep; 52(2):123-7. PubMed ID: 16443589
    [Abstract] [Full Text] [Related]

  • 9. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [Abstract] [Full Text] [Related]

  • 10. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.
    Marks LS, Dorey FJ, Rhodes T, Shery ED, Rittenhouse H, Partin AW, deKernion JB.
    J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302
    [Abstract] [Full Text] [Related]

  • 13. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer.
    Epstein JI, Walsh PC, Akingba G, Carter HB.
    J Urol; 1999 Nov; 162(5):1649-52. PubMed ID: 10524890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z, Wenlu S.
    Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A.
    Eur Urol; 2009 Mar 01; 55(3):600-6. PubMed ID: 18597923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men.
    Postma R, Schröder FH, van der Kwast TH.
    Urology; 2005 Apr 01; 65(4):745-9. PubMed ID: 15833520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.